Cargando…
Circulating anti‐p16a IgG autoantibodies as a potential prognostic biomarker for non‐small cell lung cancer
It has been reported that p16 protein is overexpressed in many types of solid cancer and its aberrant expression may trigger the immune response, leading to the secretion of anti‐p16 antibodies. Here, we developed an in‐house ELISA with three p16‐derived linear peptide antigens to examine plasma ant...
Autores principales: | Zhao, Huan, Zhang, Xuan, Han, Zhifeng, Wang, Yanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212647/ https://www.ncbi.nlm.nih.gov/pubmed/30410866 http://dx.doi.org/10.1002/2211-5463.12535 |
Ejemplares similares
-
Anti-cardiolipin IgG autoantibodies associate with circulating extracellular DNA in severe COVID-19
por: Bertin, Daniel, et al.
Publicado: (2022) -
Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris
por: Lo, Agnes S., et al.
Publicado: (2016) -
Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
por: Bi, Yanxia, et al.
Publicado: (2022) -
Rheumatoid factor IgM autoantibodies control IgG homeostasis
por: Nicolò, Antonella, et al.
Publicado: (2022) -
Plasma anti‐BIRC5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer
por: Zhao, Huan, et al.
Publicado: (2018)